Evidence map›Paper›PMID 42448948›Full record

ArticleNature chemistry2026

Programmable arene ring opening unlocks the diversification of phenols.

Yilei Huang, Han Zhu, Yichi Chen, Teng Wang, Zhibin Hu, Ming-Hui Zhu, Zengrui Cheng, Hongwei Shi, Junhong Meng, Xi Wang and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yilei Huang *State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of AI-Driven Drug Discovery and Development, New Cornerstone Science Laboratory, Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Han Zhu *State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing, China.
Yichi ChenState Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of AI-Driven Drug Discovery and Development, New Cornerstone Science Laboratory, Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Teng WangCollege of Chemistry, Beijing University of Chemical Technology, Beijing, China.ORCID http://orcid.org/0000-0003-2545-8619
Zhibin HuState Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of AI-Driven Drug Discovery and Development, New Cornerstone Science Laboratory, Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, Beijing, China.ORCID http://orcid.org/0000-0001-6782-327X
Ming-Hui ZhuState Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of AI-Driven Drug Discovery and Development, New Cornerstone Science Laboratory, Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Zengrui ChengState Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of AI-Driven Drug Discovery and Development, New Cornerstone Science Laboratory, Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, Beijing, China.ORCID http://orcid.org/0000-0003-1156-2933
Hongwei ShiState Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of AI-Driven Drug Discovery and Development, New Cornerstone Science Laboratory, Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Junhong MengState Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of AI-Driven Drug Discovery and Development, New Cornerstone Science Laboratory, Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Xi WangState Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of AI-Driven Drug Discovery and Development, New Cornerstone Science Laboratory, Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Yixian WuState Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing, China. wuyx@mail.buct.edu.cn.ORCID http://orcid.org/0000-0002-3482-4564
Ning JiaoState Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of AI-Driven Drug Discovery and Development, New Cornerstone Science Laboratory, Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, Beijing, China. jiaoning@pku.edu.cn.ORCID http://orcid.org/0000-0003-0290-9034

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inert carbon-carbon bonds of aromatic systems have long impeded the direct diversification of phenolic feedstocks into value-added scaffolds. Although enzymatic or energy-intensive strategies enable limited arene modifications, the controlled and programmable ring opening of phenols to unlock both skeletal and functional group diversity remains a fundamental challenge. Here we report an operationally simple and efficient nitrogenation strategy for cleaving phenolic arene rings, converting phenols into uniquely structured acyclic N-containing products including cyanopenta-dienoates, cyanopenta-dienamides and cyanopenta-dienoic acids. The method also enables scaffold hopping of corresponding arene rings, leading to important five-, six- and seven-membered N-heterocycles. The strategy demonstrates broad utility in late-stage modification of bioactive molecules, diversified skeletal remodelling of phenolic feedstocks, and the application of ring-opening products in polymer development. This approach transforms phenols into programmable linchpins for accessing underexplored chemical space, offering broad potential for synthetic chemistry and materials science.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.